Daily non-political popular news in brief.
First clinical trial of gene therapy for childhood blindness
05-01-2007 · EurekAlert!The first clinical trial to test a revolutionary treatment for blindness in children has been announced by researchers at UCL (University College London). The trial, funded by the Department of Health, is the first of its kind and could have a significant impact on future treatments for eye disease.
Read more »
Keywords: clinical, trial, gene, therapy, childhood, blindness
« Previous | Next »
Similar news on "First clinical trial of gene therapy for childhood blindness":
- Gene therapy safety trial for childhood blindness under way
11-19-2007 · EurekAlert!
A gene-transfer technique is being tested for safety in people in a phase 1 clinical research study of inherited blindness conducted by the University of Pennsylvania and the University of Florida with support from the National Eye Institute of the National Institutes of Health. The first adult subject underwent the procedure last week.
Similar news · Read more »
- UK scientists set their sights on cure for AMD
06-05-2007 · EurekAlert!
A groundbreaking surgical therapy capable of stabilising and restoring vision in the vast majority of patients who currently suffer blindness through Age-Related Macular Degeneration is to be taken to clinical trial by scientists and clinicians at the UCL Institute of Ophthalmology, Moorfields Eye Hospital and the University of Sheffield.
Similar news · Read more »
- Phase I study of novel gene therapy for HIV
11-06-2006 · EurekAlert!
The results are in for Phase I clinical trials of a gene therapy for AIDS. The trial was conducted at U-Penn where five patients with chronic HIV who had failed prior therapies were given a one-time infusion. They all tolerated the therapy and showed improved immune system response. This is the first publication of an effective gene therapy for AIDS to show positive clinical results in the peer review literature.
Similar news · Read more »
- Gene therapy for erectile dysfunction shows promise in clinical trial
12-01-2006 · EurekAlert!
The first human trial of gene transfer therapy for erectile dysfunction (ED) indicates that gene therapy that lasts for months and eliminates the patient's need for on-demand drugs (such as Viagra and Cialis), could become the future treatment of choice for this common problem, according to a paper in the most recent issue of Human Gene Therapy.
Similar news · Read more »
- Intravenous nanoparticle gene therapy shows activity in stage IV lung cancer
04-17-2007 · EurekAlert!
A cancer-suppressing gene has been successfully delivered into the tumors of stage four lung cancer patients via an intravenously administered lipid nanoparticle in a phase I clinical trial at the University of Texas M. D. Anderson Cancer Center. The gene, FUS1, also was found to be active in the metastatic nonsmall cell lung cancer tumors.
Similar news · Read more »
- Promising results from first gene therapy clinical trial for Parkinson's disease reported
06-21-2007 · EurekAlert!
In what could be a breakthrough in the treatment of neurological disease, a team led by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has completed the first-ever phase 1 clinical trial using gene therapy to battle Parkinson's disease.
Similar news · Read more »
- Gene therapy study shows safety and statistically significant improvement in Parkinson's disease
06-21-2007 · EurekAlert!
The first gene therapy trial for Parkinson's disease, an open label Phase 1 study in 12 patients with advanced disease, demonstrated both a lack of adverse events and statistically significant improvements from baseline in both clinical symptoms and abnormal brain metabolism (as measured by positron emission tomography, or PET scanning).
Similar news · Read more »
- Gene therapy for hereditary lung disease advances
11-21-2006 · EurekAlert!
A clinical trial to evaluate the safety of using a so-called gene vector to deliver a corrective gene to 12 patients with a common hereditary disorder that causes lung and liver disease is completed at the University of Florida. The gene therapy has caused no harmful effects in patients and hints at being effective.
Similar news · Read more »
- Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer
02-06-2008 · EurekAlert!
Henry Ford Hospital is embarking on an expanded major clinical trial involving the use of gene therapy in combination with radiation therapy, to determine if the combined treatment is more effective than radiation therapy alone for patients with intermediate risk prostate cancer.The clinical trial is part of a $9 million grant from the National Cancer Institute awarded to Henry Ford to study the effectiveness of gene therapy to treat prostate cancer.
Similar news · Read more »
- Enbrel provides sustained clinical improvements for ankylosing spondylitis for up to 3 years
11-13-2006 · EurekAlert!
Amgen (NASDAQ: AMGN) announced patients with ankylosing spondylitis who received treatment with Enbrel (R) (etanercept) experienced sustained improvement in signs and symptoms, spinal mobility and physical function over 148 to 160 weeks of therapy, according to data from an ongoing open-label, multinational, phase 4 extension study presented at the American College of Rheumatology scientific meeting. These results are consistent with an ENBREL phase 3 clinical trial at 24 weeks.
Similar news · Read more »
